ishigaki l glutathione is bfad approved Dual RNase activity of IRE1 as a target for anticancer therapies | Journal of Cell Communication and Signaling FDA Advisory No.2025-1385 || Public

Dynamic regulatory mechanisms of the signaling systems have created new clinical approaches seeking to promote the signaling, which can be achieved through manipulation of the regulatory processes

Dysbiosis and increased intestinal permeability (leaky gut) may amplify neuroinflammatory state of the brain, further justifying the need for research into interventions combining metabolic and microbiota-based therapies

If you're losing 1520% of your body weight over six months on tirzepatide, you are in a state of elevated oxidative stress

Platelet-rich plasma (PRP) is autologous (no steroid, no exogenous drug) and is increasingly supported by randomised trials and meta-analyses across common indications (knee OA, rotator cuff disease, lateral epicondylitis), with fewer systemic risks than corticosteroid injections

A secondary analysis of the WHI revealed that women aged 50 to 59 years, or those who are less than ten years post-menopause, exhibited a decreased risk of heart disease, a lower likelihood of mortality from all causes, and no significant increase in stroke risk, in contrast to women who commenced hormone therapy after the age of 60 (176)